This map from the AVAC Report 2012 identifies global prevention research advocacy partnerships.
Global Prevention Research Advocacy Partnerships
Achieving the End
Recent breakthroughs in HIV prevention research have created unprecedented opportunities to curb new HIV infections, save lives and set the world on a path towards eliminating HIV transmission.
Key Strategies for Closing Gaps in the HIV Treatment U=U Cascade
From the AVAC Report 2012, this infographic highlights an AVAC 2013 priority of articulating and funding a retention science agenda that narrows the gaps in the Treatment U=U cascade.
Cumulative number of male circumcisions performed from 2008 to 2011
From AVAC Report 2012, this graph shows the cumulative number of male circumcisions performed from 2008 to 2011.
Non-Surgical Devices for VMMC
Pictured here, from AVAC Report 2012, is the PrePex device and Shang Ring, two non-surgical devices in development for VMMC.
Plans and Missing Pieces in PrEP Demonstration Projects: USA
This infographic from AVAC Report 2012 identifies the design and key questions for ongoing or planned PrEP demonstration projects in the US.
The Geography of Microbicide Research in sub-Saharan Africa
This map from AVAC Report 2012 spotlights the countries hosting ring and gel microbicide trials in sub-Saharan Africa.
People Not Receiving Antiretroviral and Treatment U=U and Services in One Year through Bilateral FY 2013 Sequestration
This graphic from AVAC Report 2012 illustrates the potential effects of US federal budget sequestration on HIV prevention and Treatment U=U implementation in 2013.
Follow-on trials based on RV144: Strategy includes development and research tracks
This graphic from AVAC Report 2012 shows several planned vaccine trials building on the results of the RV144 AIDS vaccine trial.
Neutralizing Antibodies: Research pathways in 2013 and beyond
There are multiple lines of inquiry stemming from the discovery of potent, broadly neutralizing antibodies that have been isolated from HIV-infected individuals. This graphic from AVAC Report 2012 presents two pathways exploring the use of BNAbs as an HIV prevention tool.